PK
Individual plasma concentrations of the active drug were measured, and PK were determined using nonlinear mixed‐effect models. In all cases, when new data were available, the updated model was used for evaluation under the assumption of an allometric coefficient of 0.75 and incorporation of CYP maturation. Using a Population PK (Pop‐PK) analysis approach, AUC